Kirr Marbach & Co. LLC IN Takes Position in DENTSPLY SIRONA Inc (NASDAQ:XRAY)

Kirr Marbach & Co. LLC IN acquired a new stake in DENTSPLY SIRONA Inc (NASDAQ:XRAY) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 188,627 shares of the medical instruments supplier’s stock, valued at approximately $9,354,000. DENTSPLY SIRONA comprises about 2.3% of Kirr Marbach & Co. LLC IN’s investment portfolio, making the stock its 20th biggest holding. Kirr Marbach & Co. LLC IN owned about 0.08% of DENTSPLY SIRONA at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of the stock. FMR LLC grew its holdings in DENTSPLY SIRONA by 20.2% during the 3rd quarter. FMR LLC now owns 1,023,473 shares of the medical instruments supplier’s stock worth $38,626,000 after acquiring an additional 172,162 shares in the last quarter. Allianz Asset Management GmbH increased its stake in DENTSPLY SIRONA by 182.7% during the 3rd quarter. Allianz Asset Management GmbH now owns 51,113 shares of the medical instruments supplier’s stock valued at $1,929,000 after buying an additional 33,031 shares during the period. Riverhead Capital Management LLC grew its stake in shares of DENTSPLY SIRONA by 16.0% in the 3rd quarter. Riverhead Capital Management LLC now owns 11,225 shares of the medical instruments supplier’s stock worth $424,000 after purchasing an additional 1,550 shares during the last quarter. Jane Street Group LLC grew its stake in shares of DENTSPLY SIRONA by 63.8% in the 3rd quarter. Jane Street Group LLC now owns 38,714 shares of the medical instruments supplier’s stock worth $1,461,000 after purchasing an additional 15,072 shares during the last quarter. Finally, Pacer Advisors Inc. increased its position in shares of DENTSPLY SIRONA by 21.8% in the third quarter. Pacer Advisors Inc. now owns 21,456 shares of the medical instruments supplier’s stock worth $810,000 after acquiring an additional 3,842 shares in the last quarter. Hedge funds and other institutional investors own 99.78% of the company’s stock.

A number of analysts have issued reports on the stock. BidaskClub cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday, March 22nd. ValuEngine raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Saturday, May 4th. Barrington Research upgraded shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $63.00 target price on the stock in a research note on Monday. Zacks Investment Research downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Monday. Finally, HC Wainwright reiterated a “neutral” rating and set a $55.00 price target (up previously from $49.00) on shares of DENTSPLY SIRONA in a research report on Monday. Nine research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $53.25.

In related news, SVP Daniel P. Key purchased 3,697 shares of the stock in a transaction dated Tuesday, May 7th. The stock was bought at an average cost of $54.68 per share, with a total value of $202,151.96. Following the purchase, the senior vice president now directly owns 9,024 shares in the company, valued at approximately $493,432.32. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Markus Boehringer sold 25,300 shares of the stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $54.83, for a total value of $1,387,199.00. The disclosure for this sale can be found here. Corporate insiders own 0.62% of the company’s stock.

DENTSPLY SIRONA stock opened at $54.99 on Friday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.27 and a current ratio of 1.86. DENTSPLY SIRONA Inc has a 1 year low of $33.93 and a 1 year high of $55.88. The stock has a market cap of $12.19 billion, a price-to-earnings ratio of 27.36, a price-to-earnings-growth ratio of 2.25 and a beta of 1.11.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Friday, May 3rd. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. DENTSPLY SIRONA had a negative net margin of 26.48% and a positive return on equity of 8.98%. The company had revenue of $946.20 million for the quarter, compared to the consensus estimate of $925.13 million. During the same period in the prior year, the company posted $0.45 EPS. The company’s revenue was down 1.0% compared to the same quarter last year. On average, analysts forecast that DENTSPLY SIRONA Inc will post 2.33 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 29th were paid a $0.087 dividend. The ex-dividend date of this dividend was Thursday, March 28th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.63%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently 17.41%.

COPYRIGHT VIOLATION WARNING: “Kirr Marbach & Co. LLC IN Takes Position in DENTSPLY SIRONA Inc (NASDAQ:XRAY)” was originally reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are reading this article on another site, it was copied illegally and republished in violation of international trademark & copyright law. The original version of this article can be accessed at https://www.baseballdailydigest.com/news/2019/05/10/kirr-marbach-co-llc-in-acquires-new-position-in-dentsply-sirona-inc-xray.html.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Featured Story: Why Invest in Dividend Achievers?

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.